Core Insights - TILT Holdings Inc. is undergoing a transformation to become a streamlined, asset-light business focused on its Jupiter subsidiary, which is expected to drive sustainable growth and improve margins [2][3]. Financial Summary - Revenue for Q1 2025 was $22.7 million, a decrease from $37.5 million in the prior year period, primarily due to challenges in the Jupiter Hardware business [6]. - Gross profit was $3.4 million with a gross margin of 14.9%, down from $6.7 million and 17.9% in the previous year [6]. - The net loss for the quarter was $13.2 million, compared to a net loss of $9.7 million in the same period last year [6]. - Adjusted EBITDA was $(974) thousand, a decline from $38 thousand in the prior year [6]. - Cash flow from operating activities improved to $1.9 million from a cash used of $2.4 million in the previous year [6]. Operational Highlights - The company announced a definitive agreement to sell two Massachusetts dispensaries for $2 million, which is part of its strategy to divest plant-touching assets [6]. - TILT achieved its first EU medical device certification for its QMID handheld liquid vaporizer, enhancing its product portfolio and market potential [6][7]. - Production for Jupiter is being shifted to Indonesia to reduce tariffs and trade-related costs [7]. Strategic Focus - The CEO emphasized the importance of simplifying operations and focusing on the Jupiter brand to enhance access to capital and market expansion [2][3]. - The company is committed to technology development and product diversification to meet customer needs [3].